Veeva Vault validation for biotech
Fixed price Veeva Vault validation for small biotech teams, from the initial validation package to release impact assessments for each Veeva release.
What Veeva validates and what you still own
Veeva qualifies the platform each release. Your team still owns the risk assessment, PQ or UAT of your configuration, and change control.
Initial validation: URS, risk assessment, PQ
Validation plan, URS, risk assessment, test scripts, trace matrix and summary report for your Vault.
Release impact assessments three times a year
Each Veeva release gets a release impact assessment, a regression test scope and a validation memo.
Using CSA to keep it lean
Computer software assurance focuses testing on high risk functions. See the CSV to CSA guide.
Prices
Release Readiness is $3,500 per Veeva release. A CSA Risk Assessment is $5,000 and a SaaS validation package is $18,000. See all packages.
FAQ
- Does Veeva Vault need to be validated?
- Yes for GxP use. Veeva qualifies the platform each release, but you own the risk assessment, PQ or UAT of your configuration, and change control.
- How do you validate a Veeva release?
- Review release notes, assess impact on your configuration, test affected features in the sandbox and record the result under change control.